First Quadrant’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

First Quadrant’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-200	Closed	-$35K	–	828
2015 Q1	$35K	Hold	200	–	–	﹤0.01%	675
2014 Q4	$23K	Sell	200 -300	-60%	-$36.3K	﹤0.01%	708
2014 Q3	$78K	Hold	500	–	–	﹤0.01%	641
2014 Q2	$62K	Hold	500	–	–	﹤0.01%	683
2014 Q1	$52K	Sell	500 -200	-29%	-$20.5K	﹤0.01%	638
2013 Q4	$63K	Hold	700	–	–	﹤0.01%	663
2013 Q3	$47K	Hold	700	–	–	﹤0.01%	687
2013 Q2	$46K	Buy	+700	New	+$40K	﹤0.01%	684

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

First Quadrant's SLXP Position: Q2 2015 in Review

First Quadrant sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 200 shares — an estimated $35K sold.

First Quadrant first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $78K in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

First Quadrant reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
First Quadrant sold 200 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $35K.
First Quadrant first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
First Quadrant's SALIX PHARMACEUTICALS LTD DEL position peaked at $78K in Q3 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on First Quadrant's 13F filing for Q2 2015, filed 8 Jul 2015.